Rating History for CASI Pharmaceuticals (CASI) by Mizuho
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/2/2021 | Mara Goldstein | New Coverage | Outperform (N/A) |
3.80 (N/A) |
0.90 (0.21) |
-76.67% | Details |
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/2/2021 | Mara Goldstein | New Coverage | Outperform (N/A) |
3.80 (N/A) |
0.90 (0.21) |
-76.67% | Details |
![]() |
|||||||